Connect
MJA
MJA

Memory loss

Leon A Flicker, Andrew H Ford, Christopher D Beer and Osvaldo P Almeida
Med J Aust 2012; 196 (2): 114-117. || doi: 10.5694/mja11.11399
  • Leon A Flicker1
  • Andrew H Ford1,2
  • Christopher D Beer1
  • Osvaldo P Almeida1,2

  • 1 Western Australian Centre for Health and Ageing, University of Western Australia and Royal Perth Hospital, Perth, WA.
  • 2 School of Psychiatry and Clinical Neurosciences, University of Western Australia and Royal Perth Hospital, Perth, WA.


  • 1. Flicker L. Modifiable lifestyle risk factors for Alzheimer’s disease. J Alzheimers Dis 2010; 20: 803-811.
  • 2. World Health Organization. International statistical classification of diseases and related health problems 10th revision. http://apps.who.int/classifications/apps/icd/icd10online (accessed Jul 2011).
  • 3. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment — beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
  • 4. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153.
  • 5. LoGiudice D, Waltrowicz W, Brown K, et al. Do memory clinics improve the quality of life of carers? A randomised pilot trial. Int J Geriatr Psychiatry 1999; 14: 626-632.
  • 6. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 2004; 16: 129-140.
  • 7. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56: 37-42.
  • 8. Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006; (3): CD006104.
  • 9. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 2006; (1): CD005593.
  • 10. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141: 1356-1364.
  • 11. Schneider LS, Olin JT, Doody RS, et al. Validity and reliability of the Alzheimer’s Disease Cooperative Study–Clinical Global Impression of Change. Alzheimer Dis Assoc Disord 1997; 11 Suppl 2: S22-S32.
  • 12. Valenzuela M, Brayne C, Sachdev P, et al. Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol 2011; 173: 1004-1012.
  • 13. Australian Bureau of Statistics. Causes of death, Australia, 2009. (ABS Cat. No. 3303.0.) http://abs.gov.au/AUSSTATS/abs@.nsf/mf/3303.0 (accessed Jul 2011).
  • 14. International Psychogeriatric Association. Behavioural and psychological symptoms of dementia (BPSD) educational pack. http://www.ipa-online.net/pdfs/1BPSDfinal.pdf (accessed Jul 2011).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.